West Virginia Takes Legal Action Against Optum Over Opioid Crisis
West Virginia has filed a federal lawsuit against United Health Group Inc., claiming its pharmacy benefit management subsidiary, Optum, has contributed to the state’s opioid epidemic. The lawsuit, brought forth on Monday, alleges that Optum has oversaturated communities with addictive painkillers.
Attorney General J.B. McCaskey stated that West Virginia was already grappling with an addiction crisis when Optum began to sidestep legal protections designed to restrict opioid sales. “Optum saw a business opportunity,” McCaskey mentioned, emphasizing that the company’s choices exacerbated the situation.
As yet, United Health Group has not commented on the allegations.
Pharmacy benefit managers, like Optum, are integral in managing prescription drug benefits for various insurance firms, large employers, and Medicare. The lawsuit asserts that Optum conspired with other pharmaceutical companies to amplify the distribution of pills in West Virginia, attempted to raise daily dosage limits for opioid prescriptions, and penalized those who sought to mitigate opioid misuse.
The role of pharmacy benefit managers was to regulate which drugs would be covered and to control opioid sales by denying coverage—essentially acting as gatekeepers. However, according to the lawsuit, Optum accepted payments from drug manufacturers in exchange for loosening restrictions that allowed opioid sales.
Moreover, the complaint alleges that rather than leveraging its influence to minimize harm, Optum assisted opioid producers by planning marketing strategies and analyzing sales data to enhance opioid usage. It’s troubling that Optum also dispensed opioids via mail-order pharmacies with insufficient oversight.
In a related context, last year, Optum settled federal claims for $20 million regarding its failure to respond to warning signs when dispensing opioids through its California mail-order pharmacies.
The lawsuit includes claims of violating the West Virginia Consumer Credit Protection Act, federal RICO Act violations, negligence, and other legal matters. Interestingly, this is not West Virginia’s first legal battle over opioid management; a prior lawsuit against the pharmacy benefit manager Express Scripts was initiated in August 2025 on similar grounds, although Express Scripts has denied the allegations and is attempting to have the case dismissed.
The opioid addiction crisis in the U.S. has led to numerous lawsuits, with drug companies facing accusations of misleading marketing, particularly concerning opioid painkillers like OxyContin. Collectively, pharmaceutical companies, pharmacy chains, and distributors have consented to payments exceeding $50 billion to settle opioid-related claims with various states and local governments.
There are multiple lawsuits targeting pharmacy benefit managers over their involvement in the opioid crisis, currently consolidated in a federal multi-district litigation in Ohio.
The case is documented as West Virginia v. UnitedHealth Group, Inc., filed in the U.S. District Court for the Northern District of Virginia, No. 25-cv-00267.
